Cube Biotech Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
4
- Investments
-
1
Cube Biotech General Information
Description
Developer of crystallization products designed to serve the pharmaceutical and biotech industries. The company's products include nanodiscs, purification resins, magnetic beads, protein purification matrices, cell-free lysates and ultrapure detergent, enabling researchers to have access to membrane protein structure information.
Contact Information
Website
www.cube-biotech.comCorporate Office
- Creative Campus Monheim
- Creative-Campus-Allee 12
- 40789 Monheim
- Germany
Corporate Office
- Creative Campus Monheim
- Creative-Campus-Allee 12
- 40789 Monheim
- Germany
Cube Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cube Biotech Comparisons
Industry
Financing
Details
Cube Biotech Competitors (4)
One of Cube Biotech’s 4 competitors is antibodies-online, a Formerly VC-backed company based in Aachen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| antibodies-online | Formerly VC-backed | Aachen, Germany | ||||
| Ambrx | Formerly PE-Backed | San Diego, CA | ||||
| Lamda Biotech | Private Equity-Backed | Saint Louis, MO | ||||
| Nautilus Biotechnology | Formerly VC-backed | Seattle, WA |
Cube Biotech Patents
Cube Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026149779-A1 | Copolymers based on poly(alpha-olefin-co-maleic acid) for the solubilization, isolation and molecular labelling of membrane proteins in aqueous media | Pending | 13-Jan-2025 | ||
| WO-2026150135-A1 | Method for obtaining membrane proteins | Pending | 13-Jan-2025 | ||
| AU-2025227198-A1 | Copolymers based on poly(isobutylene-alt-maleic anhydride for the solubilization, isolation and molecular labelling of membrane proteins in aqueous media | Pending | 01-Mar-2024 | ||
| WO-2025181105-A1 | Copolymers based on poly(isobutylene-alt-maleic anhydride for the solubilization, isolation and molecular labelling of membrane proteins in aqueous media | Pending | 01-Mar-2024 | ||
| AU-2024398351-A1 | Tablets containing fuctionalized agarose particles, method for producing them and use of the tablets | Pending | 11-Dec-2023 | A61K9/205 |
Cube Biotech Signals
Cube Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cube Biotech Investments (1)
Cube Biotech’s most recent deal was a Buyout/LBO with IBA Lifesciences. The deal was made on 13-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IBA Lifesciences | 13-Jan-2025 | Buyout/LBO | Diagnostic Equipment |
Cube Biotech FAQs
-
When was Cube Biotech founded?
Cube Biotech was founded in 2012.
-
Where is Cube Biotech headquartered?
Cube Biotech is headquartered in Monheim, Germany.
-
What is the size of Cube Biotech?
Cube Biotech has 41 total employees.
-
What industry is Cube Biotech in?
Cube Biotech’s primary industry is Discovery Tools (Healthcare).
-
Is Cube Biotech a private or public company?
Cube Biotech is a Private company.
-
What is Cube Biotech’s current revenue?
The current revenue for Cube Biotech is .
-
Who are Cube Biotech’s investors?
ARCHIMED has invested in Cube Biotech.
-
Who are Cube Biotech’s competitors?
antibodies-online, Ambrx, Lamda Biotech, and Nautilus Biotechnology are competitors of Cube Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process